logo

Last Update

This profile was last updated on 3/8/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Motasim Sirhan?

Motasim Sirhan

Chief Executive Officer

Elixir Medical Corporation

HQ Phone:  (408) 636-2000

Email: m***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Elixir Medical Corporation

870 HERMOSA AVE

Sunnyvale, California,94085

United States

Company Description

Elixir Medical Corporation, a privately held company headquartered in Sunnyvale, California, develops products that combine state-of-the-art medical devices with advanced pharmaceuticals to provide innovative treatment solutions to patients worldwide. The comp...more

Web References(77 Total References)


Elixir Medical Corporation - EP Vantage Interview | Elixir Medical

elixirmedical.com [cached]

Motasim Sirhan, Elixir's CEO, tells EP Vantage that while Abbott's device may have been the first to market, it may not be the best.
The firm is "confident that we have a technology that would be best in class in the scaffold arena," he says. "We are targeting Q4 [this year] to begin commercialising our scaffold," Mr Sirhan says. Mr Sirhan is sanguine about the challenge of competing with Abbott, suggesting that the advantages of drug-eluting scaffolds mean that they could treat patients for whom DESs are unsuitable, thereby growing the market. "We're happy to have multiple players in the segment in order to push innovation and continue expanding," he says.


Elixir Medical Corporation - Press Releases Template

elixirmedical.com [cached]

However, long resorption profiles can potentially result in late and very late safety clinical events affecting patient outcomes," explained Motasim Sirhan, Chief Executive Officer of Elixir Medical.
"The 6-month results for the DESolve Cx clinical trial patients reinforce Elixir's commitment of providing cardiologists with more deliverable and user-friendly coronary scaffolds for their clinical practice," said Motasim Sirhan, Chief Executive Officer of Elixir Medical.


Apama Medicalâ„¢

www.apamamedical.com [cached]

Motasim Sirhan- Board Member
Motasim Sirhan is a serial Silicon Valley medical device entrepreneur, bringing to Apama a wealth of experience in the development and commercialization of medical products. Currently Motasim is the CEO of Elixir Medical.


Leadership - Maya-Medical - A Shifamed Company

www.maya-medical.com [cached]

Motasim Sirhan, Co-Founder
Motasim Sirhan is a serial Silicon Valley medical device entrepreneur, bringing to Apama a wealth of experience in the development and commercialization of medical products. Currently Motasim is the CEO of Elixir Medical.


Elixir Medical Corporation - Press Releases Template

elixirmedical.com [cached]

"The 6-month results for the DESolve Cx patients reinforce Elixir's commitment of providing cardiologists with the most deliverable and user-friendly coronary scaffolds in order to realize greater adoption in everyday clinical practice," said Motasim Sirhan, Chief Executive Officer of Elixir Medical.
"DESolve remains the only bioresorbable scaffold in the world that achieves lumen gain at 6 months while maintaining excellent safety and patency rate up to 4 years," said Motasim Sirhan, Chief Executive Officer of Elixir Medical.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory